5 Things a Health Plan CMO Told Us About What Moves the Needle in Behavioral Health

Dr. Frank Webster spent over a decade running behavioral health from inside the country’s largest conglomerate of not-for-profit health plans before stepping into his current role as Executive Vice President of Strategic Innovation at Meadows Mental Health Policy Institute. He was also the CMO who led that organization’s implementation of NovaOne. In a recent webinar with our own Rachel Goldberg, Dr. Webster spoke candidly about the lessons that shaped his approach to behavioral health strategy, and what he'd tell any health plan leader sitting where he used to sit.

A few of his answers stuck with us enough that we wanted to write them down.

1. Access is up, but so is spend. Where's the proof that people are getting better?
Most health plans spent the last several years solving for one main thing: increase access to get people into care faster. That mission mostly succeeded. Across the industry, more members are getting into outpatient behavioral healthcare than ever before, and outpatient spend has climbed right along with it. What most plans still cannot do is prove that spend bought better outcomes.

Dr. Webster was candid about why: when access opens up without a way to route people to the right care, more visits do not automatically mean more people getting well. He pointed to a pattern showing up across the industry, not tied to any one health plan: spend on services across all specialties including autism care continues to exponentially increase. Some of that is appropriate utilization, more people getting diagnosed and into care. And some of it is simply drifting upward, because there is no national standard for measuring outcomes across behavioral health levels of care. In a fee-for-service system, the unit that gets paid for is the visit, not the outcome.

Dr. Webster’s point wasn't that the spend is wrong necessarily. Expanding outpatient access has been the goal for decades, and the industry delivered on it. The challenge now is different: as behavioral health spend climbs without proof of the value it bought, it turns into a financial debate - and in tight markets, that debate is a hard one to win on faith.

2. Navigation: getting people to the right care, not just more of it
Anxiety is the most selected topic on our platform, month after month, across every health plan population we serve. It makes sense - most people know they don’t feel well before they fully know why. Our clinical concern is what happens next: a member decides the label fits, enters care built for anxiety and never gets to the root of what is actually driving their symptoms. As Dr. Webster put it, anxiety is often the surface layer over OCD, unresolved trauma or a substance use disorder that the member did not come in to talk about.

So, a seamless front door is often more effective than the typical directory. Start with a structured clinical assessment to understand someone’s true clinical needs, then route them into care built for what that assessment actually found. The second half only counts if the destination has evidence behind it, because not all therapy is created equal. Generalist talk therapy is not exposure and response prevention for OCD, and it is not trauma-focused treatment. They both have a similar appointment on the calendar, yet very different odds of getting well.

That standard is how NovaOne curates. A solution doesn’t earn a place on the platform for being the biggest, the best-funded or the most written-about; it earns it by proving its model works for the condition it treats. That discipline matters more as the point solution market becomes more crowded. Dr. Webster was blunt about how this compounds when health plans and employers keep adding siloed point solutions, sometimes aimed at the same condition. Without something that tells a member which one to use and why, even good solutions underperform, because people end up in the wrong one.

Navigation only counts if it points somewhere clinically excellent. Fast access into care that isn't measured, isn't evidence-based and isn't matched to what's driving the symptoms buys a faster dead end and the cost resurfaces later in poor quality of life and as spend nobody can explain. The goal was never more doors. It's the right door.

3. Measurement-based care is table stakes, not a nice-to-have
On measurement, he didn't leave room for debate: standardized instruments like the PHQ-9 need to be in use, full stop. He pushed back specifically on the argument that imperfect measurement is a reason not to measure at all, calling that "a huge mistake." The evidence he pointed to, some of it published by Meadows itself, shows that the act of measuring care improves it, independent of anything else.

There's a clinical reason, too. He described patients who reported doing great or doing terribly, only for their scores to say the opposite. That gap is a conversation starter, not a data error. His broader argument: if you want to be taken seriously as a solution or a partner in this space, measurement-informed care isn't a differentiator anymore. It's the entry fee.

4. The red flags in a point solution pitch show up in the first five minutes
Dr. Webster has sat through pitches from more than 150 behavioral health startups and point solutions. The tells repeat, and most of them surface well before the deck gets interesting.

By minute five, he usually knows whether a conversation is going anywhere.

The clearest tell: can the founder say who their customer is and what problem they solve, in two sentences, without a run-up? If not, no model underneath is going to rescue the conversation. A related version of the same problem: point solutions that pitch health plans when their real customer is providers, or the other way around. That's usually an easy thing to sort out. A quick conversation beforehand about how benefit dollars actually move and what a plan is able to buy just saves everyone time once the meeting starts. When you understand how the the healthcare system in the United States works, you have a much better idea of who the correct customer is for a given solution.

One more, subtler but revealing: how the conversation started. Warm intros are how most good conversations start, so a referral is never a strike against anyone - he just doesn't let the relationship stand in for the diligence. And badmouthing the competition? In his words, that one “just gets me.”

5. A real partnership is a shared mission, not a shared contract
Dr. Webster drew a hard line between a vendor relationship and a real partnership. Most vendor contracts, in his experience, never go beyond vendor and client. What made the NovaOne relationship different, in his words, was that both sides had already arrived at the same conclusion before the contract existed: that increasing access to the same old thing wasn't the goal.

Mission alignment wasn't the only reason he trusted the relationship. Dr. Webster and team had already independently vetted many of the same point solutions NovaOne had chosen to bring onto its platform, and NovaOne had already launched and was working with the ones he considered best in category - chosen for their clinical evidence, not their size, funding or press coverage. That was, in his words, “an immediate quality control check.” He didn't have to take NovaOne's word for who belonged in the curated network. They had already done the work himself and landed in the same place.

His framing was simple. Contractual terms and details matter, but they come after alignment on mission, not instead of it. Without that alignment first, a contract is just a contract.

Closing thoughts
 Proving that access is turning into outcomes. Building a real navigation layer across your behavioral health vendors. Figuring out which point solutions actually deserve a seat at the table. If you're working on any of these, we'd love 20 minutes with you. Get in touch with our team here.

You can listen to the entire recording on-demand here.